机译:全基因组分析表明乳腺癌对芳香化酶抑制的反应
Department of Internal Medicine, Division of Oncology, Washington University, St Louis, Missouri, USA, Siteman Cancer Center, Washington University, St Louis, Missouri 63110, USA,Breast Cancer Program, Washington University, St Louis, Missouri 63110, USA;
The Genome Institute, Washington University, St Louis, Missouri 63108, USA,Department of Genetics, Washington University, St Louis, Missouri 63108, USA;
The Genome Institute, Washington University, St Louis, Missouri 63108, USA,Department of Genetics, Washington University, St Louis, Missouri 63108, USA;
Breast Cancer Program, Washington University, St Louis, Missouri 63110, USA,Division of Biostatistics, Washington University, St Louis, Missouri 63110, USA;
AC0S0G Statistical Center, Mayo Clinic, Rochester, Minnesota 55905, USA;
机译:全基因组分析表明乳腺癌对芳香化酶抑制的反应
机译:Aristacat-芳香酶抑制作用作为晚期乳腺癌治疗的碱性Saracatinib:随机期II研究芳香酶抑制加/减去乳腺癌后绝经妇女的SRC抑制剂AZD0530
机译:芳香酸酶抑制对雌激素受体阳性乳腺癌功能基因模块的影响及其与抗增生反应的关系
机译:芳香酶抑制和乳腺癌
机译:绝经后乳腺癌幸存者在芳香酶抑制剂上的症状:基线数据的二次分析。
机译:全基因组分析通知内容乳腺癌回应抑制芳香化酶
机译:全基因组分析通知乳腺癌对芳香酶抑制的反应
机译:系统水平分析EGFR抑制-DNa损伤联合治疗乳腺癌。